Alembic Pharmaceuticals receives USFDA Tentative Approval for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg. Kumar Jeetendra | February 2, 2022 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Toviaz Extended-Release Tablets, 4 …
Alembic Pharmaceuticals announces USFDA Tentative Approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg. Kumar Jeetendra | April 7, 2022 7th April, 2022, Mumbai: Alembic Pharmaceuticals Limited today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) …
Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022 Kumar Jeetendra | May 25, 2022 Mumbai, India; May 25, 2022: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced today that is has been rated ‘STRONG’ in the Sustainability Yearbook 2022 released by CRISIL, a leading rating agency in India. Based on the fiscal 2021 data, CRISIL analysed 586 companies across 53 sectors for over …
Sartorius Launches the Octet® SF3 SPR System, Strengthening its Leadership in Advanced Label- Free Bioanalytics Kumar Jeetendra | July 4, 2022 The Life Science Group Sartorius today launched the new Octet® SF3, the first Surface Plasmon Resonance (SPR) system under the Sartorius Octet® brand. Up to now, the Octet® name has been synonymous with Bio-Layer Interferometry (BLI), a proprietary fluidic-free instrument platform for real- time, label-free analysis of biomolecular interactions. This launch establishes Sartorius as the …
High Throughput Flow Reactor for Process Chemists Kumar Jeetendra | July 4, 2022 The FlowSyn Maxi™ from Uniqsis is a high throughput flow reactor for process chemists looking to optimise reaction conditions before scaling-up synthetic production to multiple kilograms per day. Combining the benefits of proven FlowSyn technology with the capability to run at high flow rates (up to 100 ml/min) in a compact benchtop design – the …
WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility Kumar Jeetendra | July 7, 2022 SHANGHAI , July 7, 2022: WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new large-scale oligonucleotide and peptide manufacturing facility at its Changzhou campus. The new facility underscores WuXi STA’s ongoing commitment to enhance its capacity and capability to meet the fast-growing customer needs for oligonucleotide and peptide therapeutics development …
Single Use System: Future of Biopharmaceutical Industries Kumar Jeetendra | July 27, 2022 Single-use systems represent the future in biopharmaceutical processing of therapeutic drugs with significant advantages over traditional reusable stainless-steel systems and partly disposable systems. Introduction: Biopharmaceuticals include a wide range of products, such as vaccines, therapeutic proteins, blood and blood components, and tissues. In contrast to small molecule chemically synthesized drugs, which have a well-defined structure, …
Life Science Sample Tracking and Management Kumar Jeetendra | July 27, 2022 Ziath has published a new catalogue that provides an informative technical introduction to its extensive range of innovative readers, scanners, software, automated tube selectors and accessories for tracking and management of life science samples. Over the last two decades, Ziath has established itself as a global leader for sample tracking of 2D barcoded tubes in …
CIPLA launches CIPPOINT, a point-of-care gadget for non-communicable, infectious, and other disorders. Kumar Jeetendra | January 20, 2023 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the launch of Cippoint, a point-of-care testing device. This state-of-the-art device offers a wide range of testing parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. The device is CE IVD approved – …
Pharmaceutical Roots: Guaifenesin – a gift from the ‘Tree of Life’ Kumar Jeetendra | March 2, 2023 Pharmaceutical Roots is a content series from LGC Mikromol investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Introduction Worth close to $100 million in sales each year, and a staple ingredient in some of the world’s most trusted medicines for many …
Personalised virtual factory tours highlight risks and solutions for pharma and biopharma Kumar Jeetendra | March 14, 2023 Giesen, Germany, 13 March 2023 – Mettler-Toledo Product Inspection is launching new personalised virtual factory tours that will help pharma and biopharma manufacturers to improve quality assurance, regulatory compliance and consumer safety standards. The product inspection technologies on display during the virtual tours are designed to detect contaminants and help ensure high standards of quality …
Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity Kumar Jeetendra | May 6, 2023 Giesen, Germany. 4th May 2023 – Mettler-Toledo Product Inspection is showcasing a wide range of stand-alone and fully-integrated automated smart product inspection systems at Interpack 2023. The advanced product inspection technologies on Booth A60 in Hall 11 are all designed to help pharma manufacturers boost productivity, increase product safety, protect brand reputation and reduce recalls. …
